ELANE and COVID-19: Recently, some researchers suggested that neutrophil elastase inhibitors might be a potential prophylactic treatment for COVID-19 patients [11], based on evidence from basic research indicating the inhibitory effects of sivelestat on NF-κB signaling [[12], [13], [14]].